Characterization of Sexually Transmitted Infections, Their Pharmacological Treatment, and Recurrence in a Colombian Population
Overview
Authors
Affiliations
Introduction: Sexually transmitted infections are a public health problem worldwide. Their inadequate antimicrobial management has been associated with a higher risk of recurrence.
Objective: To characterize the main sexually transmitted infections, the adherence to clinical practice guidelines, and the factors associated with recurrence in Colombia.
Materials And Methods: We conducted an observational study to identify the main sexually transmitted infections, the sociodemographic variables, and the pharmacological management in a patient cohort from a population database of 6.5 million people affiliated with the Colombian health system. We made a multivariate analysis to identify the variables associated with recurrence.
Results: We detected 3,158 patients with a mean age of 41.8 ± 14.5 years, of whom 63.1% were men. We found 4.030 episodes of sexually transmitted infections, predominantly urethral syndrome (27.5%). Only 13.6% of patients with urethral syndrome, ulcerative syndrome, or genital warts were managed in compliance with clinical practice guidelines and 20.6% were dispensed condoms; 16.7% of patients had recurrences and being male (OR=1.32; 95%CI 1.08-1.63), <30 years old (OR=1.72; 95%CI 1.40-2.13), being treated in municipalities other than capital cities (OR=1.43; 95%CI 1.06-1.94), and having received inadequate treatment for the first episode (OR=1.93; 95%CI 1.52-2.39) were associated with recurrence.
Conclusions: The majority of patients with sexually transmitted infections were not treated in compliance with clinical practice guidelines and those who did not have adequate management had a higher risk of recurrence.
Evaluation and Treatment of Congenital Syphilis: A National Survey of US Pediatric Specialists.
Banks D, Flores J, Paredes J, Parzen-Johnson S J Clin Med. 2024; 13(20).
PMID: 39458235 PMC: 11508399. DOI: 10.3390/jcm13206280.
Stevenson M, Guillen J, Ortiz J, Correa J, Page K, Talero M Lancet Reg Health Am. 2024; 30:100669.
PMID: 38298201 PMC: 10827575. DOI: 10.1016/j.lana.2023.100669.